Article Information
History
- March 17, 2023.
Article Versions
- Version 1 (July 12, 2022 - 07:18).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Rachel L Williams1,2,†,
- Catherine Hyams3,4,5,†,
- Joe Robertshaw1,3,
- Maria Garcia Gonzalez4,5,
- Zsuzsa Szasz-Benczur4,
- Paul White6,
- Nick A Maskell1,
- Adam Finn4,
- Shaney L Barratt1,3 and
- the AvonCAP Research Group
- 1Academic Respiratory Unit, University of Bristol, North Bristol NHS Trust, Southmead, Bristol, BS10 5NB
- 2Research and Innovation, North Bristol NHS Trust, Southmead, Bristol BS10 5NB
- 3Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Southmead, Bristol BS10 5NB
- 4Bristol Vaccine Centre, Schools of Population Health Sciences and Cellular and Molecular Medicine, University of Bristol, Bristol, BS2 8AE
- 5Vaccine and Testing Team, UHBW NHS Trust, Bristol
- 6University of the West of England, Bristol, BS16 1QY
- Correspondence to:
Dr Shaney Barratt, Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Southmead Hospital, Bristol BS10 5NB, UK shaney.barratt{at}nbt.nhs.uk
↵† These authors contributed equally to this work
Posted March 17, 2023.
Use of illness severity scores to predict mortality in interstitial lung disease patients hospitalised with acute respiratory deterioration
